- cafead   Sep 05, 2023 at 11:42: AM
via
article source
- Eli Lilly is making big plays in three hot markets: Alzheimer's, pain, and obesity.
- It's already on the cusp of getting medicines approved in those spaces.
- The next three to five years will likely be very good ones for shareholders.
article source